These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Probing the pore drug binding site of microtubules with fluorescent taxanes: evidence of two binding poses. Barasoain I; García-Carril AM; Matesanz R; Maccari G; Trigili C; Mori M; Shi JZ; Fang WS; Andreu JM; Botta M; Díaz JF Chem Biol; 2010 Mar; 17(3):243-53. PubMed ID: 20338516 [TBL] [Abstract][Full Text] [Related]
26. Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity. Buey RM; Díaz JF; Andreu JM; O'Brate A; Giannakakou P; Nicolaou KC; Sasmal PK; Ritzén A; Namoto K Chem Biol; 2004 Feb; 11(2):225-36. PubMed ID: 15123284 [TBL] [Abstract][Full Text] [Related]
27. [TUBB3 role in the response of tumor cells to epothilones and taxanes]. Marczak A; Rogalska A Postepy Hig Med Dosw (Online); 2015 Jan; 69():158-64. PubMed ID: 25661915 [TBL] [Abstract][Full Text] [Related]
28. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers. Wang R; Wang H; Wang Z J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508 [TBL] [Abstract][Full Text] [Related]
29. Taxane- and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma. Alberti C Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1658-64. PubMed ID: 23832735 [TBL] [Abstract][Full Text] [Related]
30. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro. Cai P; Lu P; Sharom FJ; Fang WS Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826 [TBL] [Abstract][Full Text] [Related]
31. [Drugs from nature. The biology of taxane]. Leistner E Pharm Unserer Zeit; 2005; 34(2):98-103. PubMed ID: 15803792 [No Abstract] [Full Text] [Related]
32. Structural Basis of Microtubule Stabilization by Discodermolide. Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984 [TBL] [Abstract][Full Text] [Related]
33. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site. Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of methoxylated analogs of the newer generation taxoids IDN5109 and IDN5390. Barboni L; Ballini R; Giarlo G; Appendino G; Fontana G; Bombardelli E Bioorg Med Chem Lett; 2005 Dec; 15(23):5182-6. PubMed ID: 16183281 [TBL] [Abstract][Full Text] [Related]
35. Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. Ferlini C; Distefano M; Pignatelli F; Lin S; Riva A; Bombardelli E; Mancuso S; Ojima I; Scambia G Br J Cancer; 2000 Dec; 83(12):1762-8. PubMed ID: 11104578 [TBL] [Abstract][Full Text] [Related]
36. The discovery of BMS-275183: an orally efficacious novel taxane. Mastalerz H; Cook D; Fairchild CR; Hansel S; Johnson W; Kadow JF; Long BH; Rose WC; Tarrant J; Wu MJ; Xue MQ; Zhang G; Zoeckler M; Vyas DM Bioorg Med Chem; 2003 Oct; 11(20):4315-23. PubMed ID: 13129567 [TBL] [Abstract][Full Text] [Related]
37. Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer. Cassinelli G; Lanzi C; Supino R; Pratesi G; Zuco V; Laccabue D; Cuccuru G; Bombardelli E; Zunino F Clin Cancer Res; 2002 Aug; 8(8):2647-54. PubMed ID: 12171897 [TBL] [Abstract][Full Text] [Related]